Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease

Clinical Cardiology

Volumn 22, Issue 2, 1999, Pages 85-90

  Altman, Raul ^a,b   Rouvier, Jorge ^a   Scazziota, Alejandra ^a   Absi, Ruben S ^a   Gonzalez, Claudio ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centro de Trombosis de Buenos Aires   (Argentina)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Coronary disease

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID;

ANTIBODY TITER; ARTERY DISEASE; ARTICLE; BACTERIUM ISOLATION; BLOOD PRESSURE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; RISK FACTOR; SEROPREVALENCE; THROMBOEMBOLISM;

EID: 0345369286     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960220206     Document Type: Article

References (23)

1. Metha JL, Saldeen TGP, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-1225
2. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P: Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-1134
3. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Vatonen V: Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2: 983-985
4. Thom DH, Grayston T, Siscovick DS, Wang S, Weiss NS, Daling JR: Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc 1992;268:68-72
5. Thom DH, Wang SP, Grayston T, Siscovick DS, Stewart DK, Kronmal RA, Weiss NS: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11:547-551
6. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman M, Manninen V, Mäntäri M, Frick MH, Huttunen JK: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116: 274-278
7. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamyilia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-407
8. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL: Increased incidence of chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-1561
9. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA, 1995;92: 6911-6914
10. Grayston JT, Kuo C, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Soundness ED, Wang S: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92: 3397-3400
11. Ramirez JA, and the Chlamydia pneumoniae/atherosclerosis study group: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-982
12. Chiu B, Viira E, Tucker W, Fong IW: Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-2148
13. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97: 633-636
14. Godzik KL, O'Brien ER, Wang SK, Kuo C: In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-2414
15. Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie AGG: Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 1996;94:2113-2116
16. Hahn DL, Golubjatnikov R: Smoking is a potential confounder of the Chlamydia pneumoniae-coromay artery disease association. Arteroscler Thromb 1992;12:945-947
17. Tong CYW, Potter F, Worthington E, Mullins P: Chlamydia pneumoniae myocarditis. Lancet 1995;346:710-711
18. Gurfinkel E, Duronto E, Cerda M, Gomez Carretero L, Bozovich G, Rosloznik J, Daroca A, Mautner B: Patients with unstable angina related with C reactive protein and Chlamydia pneumoniae infection (abstr). Eur Heart J 1996 (suppl);17:578
19. Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson: Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 1992; 340:427-428
20. Campbell LA, Moazed TC, Kuo CC, Grayston JT: Mouse models of atherosclerosis and Chlamydia pneumoniae (abstr). Proc Third Eur Soc Chlam Res 1996;3:106
21. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA: Fibrinogen: A link between chronic infection and coronary heart disease. Lancet 1994;343:1634-1635
22. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997;96:4095-4103
23. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: Is there a link? Lancet 1997;350:430-436